Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Feb 1;101(3):588–594. doi: 10.1172/JCI1283

Two aberrant splicings caused by mutations in the insulin receptor gene in cultured lymphocytes from a patient with Rabson-Mendenhall's syndrome.

Y Takahashi 1, H Kadowaki 1, A Ando 1, J D Quin 1, A C MacCuish 1, Y Yazaki 1, Y Akanuma 1, T Kadowaki 1
PMCID: PMC508602  PMID: 9449692

Abstract

Rabson-Mendenhall's syndrome is one of the most severe forms of insulin resistance syndrome. We analyzed an English patient described elsewhere and found novel mutations in both alleles of the insulin receptor gene. One is a substitution of G for A at the 3' splice acceptor site of intron 4, and the other is an eight-base pair deletion in exon 12. Both decrease mRNA expression in a cis-dominant manner, and are predicted to produce severely truncated proteins. Surprisingly, nearly normal insulin receptor levels were expressed in the patient's lymphocytes, although the level of expression assessed by immunoblot was approximately 10% of the control cells. Insulin binding affinity was markedly reduced, but insulin-dependent tyrosine kinase activity was present. Analyzing the insulin receptor mRNA of the patient's lymphocytes by reverse transcription PCR, we discovered aberrant splicing caused by activation of a cryptic splice site in exon 5, resulting in a four-amino acid deletion and one amino acid substitution, but restoring an open reading frame. Skipped exon 5, another aberrant splicing, was found in both the patient and the mother who had the heterozygotic mutation, whereas activation of the cryptic splice site occurred almost exclusively in the patient. Transfectional analysis in COS cells revealed that the mutant receptor produced by cryptic site activation has the same characteristics as those expressed in patient's lymphocytes. We speculate that this mutant receptor may be involved in the relatively long survival of the patient by rescuing otherwise more severe phenotypes resulting from the complete lack of functional insulin receptors.

Full Text

The Full Text of this article is available as a PDF (295.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berget S. M. Exon recognition in vertebrate splicing. J Biol Chem. 1995 Feb 10;270(6):2411–2414. doi: 10.1074/jbc.270.6.2411. [DOI] [PubMed] [Google Scholar]
  2. Cáceres J. F., Stamm S., Helfman D. M., Krainer A. R. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science. 1994 Sep 16;265(5179):1706–1709. doi: 10.1126/science.8085156. [DOI] [PubMed] [Google Scholar]
  3. Dietz H. C., Valle D., Francomano C. A., Kendzior R. J., Jr, Pyeritz R. E., Cutting G. R. The skipping of constitutive exons in vivo induced by nonsense mutations. Science. 1993 Jan 29;259(5095):680–683. doi: 10.1126/science.8430317. [DOI] [PubMed] [Google Scholar]
  4. Feener E. P., Backer J. M., King G. L., Wilden P. A., Sun X. J., Kahn C. R., White M. F. Insulin stimulates serine and tyrosine phosphorylation in the juxtamembrane region of the insulin receptor. J Biol Chem. 1993 May 25;268(15):11256–11264. [PubMed] [Google Scholar]
  5. Flier J. S. Lilly Lecture: syndromes of insulin resistance. From patient to gene and back again. Diabetes. 1992 Sep;41(9):1207–1219. doi: 10.2337/diab.41.9.1207. [DOI] [PubMed] [Google Scholar]
  6. Goguel V., Rosbash M. Splice site choice and splicing efficiency are positively influenced by pre-mRNA intramolecular base pairing in yeast. Cell. 1993 Mar 26;72(6):893–901. doi: 10.1016/0092-8674(93)90578-e. [DOI] [PubMed] [Google Scholar]
  7. Izumi T., Saeki Y., Akanuma Y., Takaku F., Kasuga M. Requirement for receptor-intrinsic tyrosine kinase activities during ligand-induced membrane ruffling of KB cells. Essential sites of src-related growth factor receptor kinases. J Biol Chem. 1988 Jul 25;263(21):10386–10393. [PubMed] [Google Scholar]
  8. Kaburagi Y., Momomura K., Yamamoto-Honda R., Tobe K., Tamori Y., Sakura H., Akanuma Y., Yazaki Y., Kadowaki T. Site-directed mutagenesis of the juxtamembrane domain of the human insulin receptor. J Biol Chem. 1993 Aug 5;268(22):16610–16622. [PubMed] [Google Scholar]
  9. Kaburagi Y., Yamamoto-Honda R., Tobe K., Ueki K., Yachi M., Akanuma Y., Stephens R. M., Kaplan D., Yazaki Y., Kadowaki T. The role of the NPXY motif in the insulin receptor in tyrosine phosphorylation of insulin receptor substrate-1 and Shc. Endocrinology. 1995 Aug;136(8):3437–3443. doi: 10.1210/endo.136.8.7543044. [DOI] [PubMed] [Google Scholar]
  10. Kadowaki H., Takahashi Y., Ando A., Momomura K., Kaburagi Y., Quin J. D., MacCuish A. C., Koda N., Fukushima Y., Taylor S. I. Four mutant alleles of the insulin receptor gene associated with genetic syndromes of extreme insulin resistance. Biochem Biophys Res Commun. 1997 Aug 28;237(3):516–520. doi: 10.1006/bbrc.1997.7181. [DOI] [PubMed] [Google Scholar]
  11. Kadowaki T., Bevins C. L., Cama A., Ojamaa K., Marcus-Samuels B., Kadowaki H., Beitz L., McKeon C., Taylor S. I. Two mutant alleles of the insulin receptor gene in a patient with extreme insulin resistance. Science. 1988 May 6;240(4853):787–790. doi: 10.1126/science.2834824. [DOI] [PubMed] [Google Scholar]
  12. Krook A., Brueton L., O'Rahilly S. Homozygous nonsense mutation in the insulin receptor gene in infant with leprechaunism. Lancet. 1993 Jul 31;342(8866):277–278. doi: 10.1016/0140-6736(93)91820-c. [DOI] [PubMed] [Google Scholar]
  13. Moller D. E., Flier J. S. Insulin resistance--mechanisms, syndromes, and implications. N Engl J Med. 1991 Sep 26;325(13):938–948. doi: 10.1056/NEJM199109263251307. [DOI] [PubMed] [Google Scholar]
  14. O'Rahilly S., Moller D. E. Mutant insulin receptors in syndromes of insulin resistance. Clin Endocrinol (Oxf) 1992 Feb;36(2):121–132. doi: 10.1111/j.1365-2265.1992.tb00945.x. [DOI] [PubMed] [Google Scholar]
  15. Quin J. D., Fisher B. M., Paterson K. R., Inoue A., Beastall G. H., MacCuish A. C. Acute response to recombinant insulin-like growth factor I in a patient with Mendenhall's syndrome. N Engl J Med. 1990 Nov 15;323(20):1425–1426. doi: 10.1056/NEJM199011153232016. [DOI] [PubMed] [Google Scholar]
  16. Rolfini R., Cabrini G. Nonsense mutation R1162X of the cystic fibrosis transmembrane conductance regulator gene does not reduce messenger RNA expression in nasal epithelial tissue. J Clin Invest. 1993 Dec;92(6):2683–2687. doi: 10.1172/JCI116885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Seino S., Seino M., Bell G. I. Human insulin-receptor gene. Partial sequence and amplification of exons by polymerase chain reaction. Diabetes. 1990 Jan;39(1):123–128. doi: 10.2337/diacare.39.1.123. [DOI] [PubMed] [Google Scholar]
  18. Takahashi Y., Kadowaki H., Momomura K., Fukushima Y., Orban T., Okai T., Taketani Y., Akanuma Y., Yazaki Y., Kadowaki T. A homozygous kinase-defective mutation in the insulin receptor gene in a patient with leprechaunism. Diabetologia. 1997 Apr;40(4):412–420. doi: 10.1007/s001250050695. [DOI] [PubMed] [Google Scholar]
  19. Taouis M., Levy-Toledano R., Roach P., Taylor S. I., Gorden P. Structural basis by which a recessive mutation in the alpha-subunit of the insulin receptor affects insulin binding. J Biol Chem. 1994 May 27;269(21):14912–14918. [PubMed] [Google Scholar]
  20. Taylor S. I. Lilly Lecture: molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin-receptor gene. Diabetes. 1992 Nov;41(11):1473–1490. doi: 10.2337/diab.41.11.1473. [DOI] [PubMed] [Google Scholar]
  21. Ullrich A., Bell J. R., Chen E. Y., Herrera R., Petruzzelli L. M., Dull T. J., Gray A., Coussens L., Liao Y. C., Tsubokawa M. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. 1985 Feb 28-Mar 6Nature. 313(6005):756–761. doi: 10.1038/313756a0. [DOI] [PubMed] [Google Scholar]
  22. Will K., Dörk T., Stuhrmann M., Meitinger T., Bertele-Harms R., Tümmler B., Schmidtke J. A novel exon in the cystic fibrosis transmembrane conductance regulator gene activated by the nonsense mutation E92X in airway epithelial cells of patients with cystic fibrosis. J Clin Invest. 1994 Apr;93(4):1852–1859. doi: 10.1172/JCI117172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Winnard A. V., Mendell J. R., Prior T. W., Florence J., Burghes A. H. Frameshift deletions of exons 3-7 and revertant fibers in Duchenne muscular dystrophy: mechanisms of dystrophin production. Am J Hum Genet. 1995 Jan;56(1):158–166. [PMC free article] [PubMed] [Google Scholar]
  24. Wu J. Y., Maniatis T. Specific interactions between proteins implicated in splice site selection and regulated alternative splicing. Cell. 1993 Dec 17;75(6):1061–1070. doi: 10.1016/0092-8674(93)90316-i. [DOI] [PubMed] [Google Scholar]
  25. Yamamoto R., Shiba T., Tobe K., Shibasaki Y., Koshio O., Izumi T., Odawara M., Mikami Y., Matsuura N., Akanuma Y. Defect in tyrosine kinase activity of the insulin receptor from a patient with insulin resistance and acanthosis nigricans. J Clin Endocrinol Metab. 1990 Apr;70(4):869–878. doi: 10.1210/jcem-70-4-869. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES